Serveur d'exploration sur la COVID en France - Exploration (Accueil)

Index « Keywords » - entrée « Antiviral Agents (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antiviral Agents (administration & dosage) < Antiviral Agents (adverse effects) < Antiviral Agents (blood)  Facettes :

List of bibliographic references indexed by Antiviral Agents (adverse effects)

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000011 (2020) Matthieu Million [France] ; Jean-Christophe Lagier [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Pierre-Edouard Fournier [France] ; Sophie Amrane [France] ; Marie Hocquart [France] ; Morgane Mailhe [France] ; Vera Esteves-Vieira [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Florian Correard [France] ; Audrey Giraud-Gatineau [France] ; Yanis Roussel [France] ; Cyril Berenger [France] ; Nadim Cassir [France] ; Piseth Seng [France] ; Christine Zandotti [France] ; Catherine Dhiver [France] ; Isabelle Ravaux [France] ; Christelle Tomei [France] ; Carole Eldin [France] ; Hervé Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Eric Chabrière [France] ; Anthony Levasseur [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Bernard La Scola [France] ; Philippe Parola [France] ; Didier Raoult [France]Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
000152 (2020) H. Javelot [France] ; P-M Llorca [France] ; D. Drapier [France] ; E. Fakra [France] ; C. Hingray [France] ; G. Meyer [France] ; S. Dizet [France] ; A. Egron [France] ; C. Straczek [France] ; M. Roser [France] ; M. Masson [France] ; R. Gaillard [France] ; P. Fossati [France] ; E. Haffen [France][Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].
000195 (2020) H. Javelot [France] ; P-M Llorca [France] ; G. Meyer [France] ; P. Fossati [France] ; E. Haffen [France][Challenges for psychotropics in the context of the SARS-Cov-2 pandemic].
000286 (2020) Frederic Sacher [France] ; Laurent Fauchier [France] ; Serge Boveda [France] ; Christian De Chillou [France] ; Pascal Defaye [France] ; Jean Claude Deharo [France] ; Estelle Gandjbakhch [France] ; Vincent Probst [France] ; Ariel Cohen [France] ; Christophe Leclercq [France]Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection.
000889 (2020) S. Tunesi [France] ; A. Bourgarit [France]Prescribing COVID-19 treatments: what we should never forget.
000950 (2020) Laure Elens [Belgique] ; Loralie J. Langman [États-Unis] ; Dennis A. Hesselink [Pays-Bas] ; Stein Bergan [Norvège] ; Dirk Jan A R. Moes [Pays-Bas] ; Mariadelfina Molinaro [Italie] ; Raman Venkataramanan [États-Unis] ; Florian Lemaitre [France]Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.
000A31 (2020) Franck Touret [France] ; Xavier De Lamballerie [France]Of chloroquine and COVID-19.
000B81 (2020) Christophe Beyls [France] ; Nicolas Martin [France] ; Alexis Hermida [France] ; Osama Abou-Arab [France] ; Yazine Mahjoub [France]Lopinavir-Ritonavir Treatment for COVID-19 Infection in Intensive Care Unit: Risk of Bradycardia.
001107 (2020) Alexandre Olry [France] ; Lucy Meunier [France] ; Bénédicte Délire [Belgique] ; Dominique Larrey [France] ; Yves Horsmans [Belgique] ; Hervé Le Louët [France]Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same.
001283 (2020) Jonathan Grein ; Norio Ohmagari ; Daniel Shin ; George Diaz ; Erika Asperges ; Antonella Castagna ; Torsten Feldt ; Gary Green ; Margaret L. Green ; François-Xavier Lescure ; Emanuele Nicastri ; Rentaro Oda ; Kikuo Yo ; Eugenia Quiros-Roldan ; Alex Studemeister ; John Redinski ; Seema Ahmed ; Jorge Bernett ; Daniel Chelliah ; Danny Chen ; Shingo Chihara ; Stuart H. Cohen ; Jennifer Cunningham ; Antonella D'Arminio Monforte ; Saad Ismail ; Hideaki Kato ; Giuseppe Lapadula ; Erwan L'Her ; Toshitaka Maeno ; Sumit Majumder ; Marco Massari ; Marta Mora-Rillo ; Yoshikazu Mutoh ; Duc Nguyen ; Ewa Verweij ; Alexander Zoufaly ; Anu O. Osinusi ; Adam Dezure ; Yang Zhao ; Lijie Zhong ; Anand Chokkalingam ; Emon Elboudwarej ; Laura Telep ; Leighann Timbs ; Ilana Henne ; Scott Sellers ; Huyen Cao ; Susanna K. Tan ; Lucinda Winterbourne ; Polly Desai ; Robertino Mera ; Anuj Gaggar ; Robert P. Myers ; Diana M. Brainard ; Richard Childs ; Timothy FlaniganCompassionate Use of Remdesivir for Patients with Severe Covid-19.
001386 (2020) Efstathios Kastritis [Grèce] ; Ashutosh Wechalekar [Royaume-Uni] ; Stefan Schönland [Allemagne] ; Vaishali Sanchorawala [États-Unis] ; Giampaolo Merlini [Italie] ; Giovanni Palladini [Italie] ; Monique Minnema [Pays-Bas] ; Murielle Roussel [France] ; Arnaud Jaccard [France] ; Ute Hegenbart [Allemagne] ; Shaji Kumar [États-Unis] ; Maria T. Cibeira [Espagne] ; Joan Blade [Espagne] ; Meletios A. Dimopoulos [Grèce]Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic.
001395 (2020) Marie Dubert [France] ; Benoit Visseaux [France] ; Valentina Isernia [France] ; Lila Bouadma [France] ; Laurène Deconinck [France] ; Juliette Patrier [France] ; Paul-Henri Wicky [France] ; Diane Le Pluart [France] ; Laura Kramer [France] ; Christophe Rioux [France] ; Quentin Le Hingrat [France] ; Nadhira Houhou-Fidouh [France] ; Yazdan Yazdanpanah [France] ; Jade Ghosn [France] ; Francois-Xavier Lescure [France]Case report study of the first five COVID-19 patients treated with remdesivir in France.
001468 (2020) Hassan Izzedine [France] ; Kenar D. Jhaveri [États-Unis] ; Mark A. Perazella [États-Unis]COVID-19 therapeutic options for patients with kidney disease.
001695 (2020) Paul Gougis [France] ; Charlotte Fenioux [France] ; Christian Funck-Brentano [France] ; Marianne Veyri [France] ; Joseph Gligorov [France] ; Caroline Solas [France] ; Jean-Philippe Spano [France]Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?
001771 (2020) Olivier Voisin [France] ; Erwan Le Lorc'H [France] ; Annabelle Mahé [France] ; Philippe Azria [France] ; Marie-Françoise Borie [France] ; Sidonie Hubert [France] ; Elodie Ménage [France] ; Jean-Christophe Guillerm [France] ; Jean-Jacques Mourad [France]Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection.
001854 (2020) Keisha Smith [États-Unis] ; Amy Pace [États-Unis] ; Stephan Ortiz [États-Unis] ; Shamsah Kazani [États-Unis] ; Scott Rottinghaus [États-Unis]A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antiviral Agents (adverse effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antiviral Agents (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiviral Agents (adverse effects)
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021